Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Kumari vitamin Cstandard of careCOVID-19 severe or criticallyNA
75/75 inconclusive
    COVID-VIT-D
     
    NCT04552951
    RCTVitamin DcontrolCOVID-19 severe or criticallyhigh
    274/269 inconclusive
      Jamali Moghadam Siahkali
       
      IRCT20200411047025N1
      RCTvitamin Cstandard of careCOVID-19 severe or criticallyhigh
      30/30 inconclusive
        Zhang
         
        NCT04264533
        RCTvitamin CplaceboCOVID-19 severe or criticallysome concern
        27/29 inconclusive

          PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
          Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).